Issue 4/2022
Content (7 Articles)
Weekly Supervised Administration of Oral Antipsychotics: An Alternative to Long-Acting Injections?
Sofia Brissos, David Taylor
Slowing Parkinson’s Disease Progression with Vaccination and Other Immunotherapies
Dhanya Vijayakumar, Joseph Jankovic
Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis
Niall M. McGowan, David S. Kim, Marta de Andres Crespo, Lampros Bisdounis, Simon D. Kyle, Kate E. A. Saunders
Role of Pharmacogenomics in Individualizing Treatment for Alzheimer’s Disease
Natalie Argueta, Emily Notari, Kinga Szigeti
Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
Thomas Roth, Yves Dauvilliers, Michael J. Thorpy, Clete Kushida, Bruce C. Corser, Richard Bogan, Russell Rosenberg, Jordan Dubow, David Seiden
Signals of Muscle Relaxant Drug Interactions Associated with Unintentional Traumatic Injury: A Population-Based Screening Study
Ghadeer K. Dawwas, Sean Hennessy, Colleen M. Brensinger, Emily K. Acton, Warren B. Bilker, Sophie Chung, Sascha Dublin, John R. Horn, Melanie M. Manis, Todd A. Miano, David W. Oslin, Thanh Phuong Pham Nguyen, Samantha E. Soprano, Douglas J. Wiebe, Charles E. Leonard
Risdiplam: A Review in Spinal Muscular Atrophy
Julia Paik